Chief Executive Officer
CurrentChr. Olesen Synthesis manufactures APIs and is 50% owned by a danish family company (Chr. Olesen) and 50% owned by Signet Healthcare (US, equity)
Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Thomas Moestrup is listed as CEO l Pharma Industry l MBA & M.Sc. at Chr. Olesen Synthesis A/S, based in Gladsaxe, Capital Region of Denmark, Denmark. AeroLeads shows a matched LinkedIn profile for Thomas Moestrup.
Thomas Moestrup previously worked as Chief Executive Officer at Chr. Olesen Synthesis A/S and Chief Commercial Officer at Chr. Olesen Synthesis A/S. Thomas Moestrup holds Executive Mba, Business Administration And Management from Copenhagen Business School.
This section adds company-level context without repeating Thomas Moestrup's masked contact details.
Review company-level records connected to Thomas Moestrup before choosing the right outreach path.
20 years of senior management experience within the life science industry as for example CEO, GM and commercial director. Main responsibility has been execution of ambitious growth strategies through strategic partnerships with customers, distributors & suppliers. I have a broad understanding of the full value chain in especially B2B business and have been in the role as the supplier as well as the buyer. A highly trained and experienced leader profile with a good understanding of the commercial and operational side of the life science industry. Focused, committed and ambitious on an empathetic basis, involving respect and recognition for others, among whom I'm seen as diplomatic, action-oriented and visible. RESULTS:Implemented successful turnaround strategies 3-time Gazelle (Danish business award) received for high growth resultsLaunching of new products & brands that have beaten established competitorsEstablished successful partnerships with major pharma & food companies Restructured organizations as well as integrated different company culturesPROFILE:Management: Cross functional management in Pharma/nutraceutical & specialty ingredient industryCoordination and planning cross units and business areas locally and internationallyP&L responsibility, (10M Euro).Report and sparring with the board of directors.Staff management (50+ employees):Coaching, sparring and competence development of leaders and employeesStrong motivational skills - with focus on individual needsA strong believer in delegation of power and tasksClear KPI communication and follow upSales & Marketing: Primarily functioned in B2B environments, but also with some B2C experienceKey account management (top pharma/food companies + major retail and pharmacy chains)Strategic marketing planningBrand building on known and new markets including corporate brandingEmail: moestrup23@gmail.comPhone: +45 20 15 66 65
Listed skills include Management, Product Development, Pharmaceutical Industry, Business Strategy, and 36 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Hvidovre (Copenhagen), Dk
Chr. Olesen Synthesis manufactures APIs and is 50% owned by a danish family company (Chr. Olesen) and 50% owned by Signet Healthcare (US, equity)
Hellerup, Hovedstaden, Dk
I have in my role as GM at Cell Biotech Int. obtained solid results, particularly in regards to a successful implementation of a new growth strategy, which has resulted in a 70-80% increase in revenue. This was after several years of negative revenue trending. Furthermore our branded portfolio of probiotics "Duolac" more than doubled its revenue and as a relatively new brand established one of the top positions in a highly competitive market.Primary responsibilities: - General management- Establish and implement new strategy- New corporate identity - Growing the European market for branded probiotics. - Successful launch of a new product line - Launch of new online sales channel- In charge of the European market- Partnerships with companies all over Europe (big pharma and medium sized health care companies)- Contract negotiations- Supplier relations- P&L
Graested, Dk
- General management- performance strategies- Commercial/marketing strategy - development and implementation - Development of organization and employees - Contract and pricing (in/out sourcing)
- Contract manufacturing (pharma, food supplements, cosmetics)- Rebuild customer portfolio- Management of total value chain- Integrated Propharma in a larger organization- Cut product costs with 25-35% by optimizing SupplyChain- Increased revenue and profit
- Approval of a new factory by the Danish Medicines Agency
Quick answers generated from the profile data available on this page.
Thomas Moestrup works for Chr. Olesen Synthesis A/S.
Thomas Moestrup is listed as CEO l Pharma Industry l MBA & M.Sc. at Chr. Olesen Synthesis A/S.
Thomas Moestrup is based in Gladsaxe, Capital Region of Denmark, Denmark while working with Chr. Olesen Synthesis A/S.
Thomas Moestrup has worked for Chr. Olesen Synthesis A/S, Cell Biotech International A/S, Persano Group, and Propharma A/S.
You can use AeroLeads to view verified contact signals for Thomas Moestrup at Chr. Olesen Synthesis A/S, including work email, phone, and LinkedIn data when available.
Thomas Moestrup holds Executive Mba, Business Administration And Management from Copenhagen Business School.
Thomas Moestrup is listed with skills including Management, Product Development, Pharmaceutical Industry, Business Strategy, Team Leadership, Leadership, Business Planning, and Strategic Planning.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts